CSIMarket Company Name, Ticker, Suppliers, else..
 

Talphera Inc   (NASDAQ: TLPH)

Talphera Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

TLPH Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Talphera Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 1.94 %, recorded in the same quarter.

• List of TLPH Competitors





Revenue Growth Comparisons




Net Income Comparison

Talphera Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  TLPH Stock Performance Comparisons


Talphera Inc 's Comment on Competition and Industry Peers


The company faces competition from lower-priced pharmaceutical products in foreign countries with price controls. Imported foreign products may also pose competitive challenges that could affect profitability. Legislative and regulatory changes in the U.S. and internationally, including efforts to reduce healthcare costs and government payment policies, may influence the company's ability to commercialize products profitably and impact sales if competitors lower prices or demonstrate greater cost-effectiveness.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Talphera Inc




Diamedica Therapeutics Inc
Share Performance



-3.11%
30 Days
Diamedica Therapeutics Inc
Profile

Diamedica Therapeutics Inc's business model focuses on developing and commercializing innovative therapies to improve patient outcomes in areas of unmet medical needs.

More about Diamedica Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 352.469 mill. $ - mill. $ -37.541 mill.


Emmaus Life Sciences Inc
Share Performance



0.00%
Over The Past 5 Days
Emmaus Life Sciences Inc
Profile

Emmaus Life Sciences Inc's business model revolves around the development and commercialization of innovative pharmaceutical products, with a focus on the treatment and management of rare diseases and conditions. They aim to bring these life-saving therapies to market by conducting research, obtaining regulatory approvals, and establishing partnerships with healthcare providers and stakeholders.

More about Emmaus Life Sciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3.586 mill. $ 12.166 mill. $ -7.164 mill.


Amicus Therapeutics inc
Share Performance



+0.21%
Over The Past 5 Days
Amicus Therapeutics inc
Profile

Amicus Therapeutics Inc is a biopharmaceutical company that focuses on the development and commercialization of therapies for rare and orphan diseases.

More about Amicus Therapeutics inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,468.191 mill. $ 632.828 mill. $ -27.110 mill.


Galmed Pharmaceuticals Ltd
Share Performance



+535.38%
30 Days
Galmed Pharmaceuticals Ltd
Profile

Galmed Pharmaceuticals Ltd's business model focuses on the development and commercialization of innovative therapeutic solutions, particularly in the field of liver and metabolic diseases.

More about Galmed Pharmaceuticals Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.061 mill. $ - mill. $ 1.400 mill.


Immuron Limited
Share Performance



+78.47%
30 Days
Immuron Limited
Profile

Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases.

More about Immuron Limited's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 6.765 mill. $ -5.216 mill.

17 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Talphera Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Talphera Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.